15 / 24
Page 50
Day 2 June 27, 2017
Sessions
Cancer stem cell | Molecular Medicines for Cancers| Stem cell markers | Breast Cancer Stem
Cells | Cancer Stem Cells in Brain Gliomas
Session Chair
Chiara Mondello
Institute of Molecular Genetics, Italy
Title:
Use of 3D spheroid cultures to screen for drugs targeting cancer stem cells
Ines Prieto,
StemTek Therapeutics, Derio, Spain
Title:
Chemotherapy curable malignancies; Unique genetic events, frozen development, natural apoptosis
and absent cancer stem cells
Philip Savage,
Brighton and Sussex University Hospitals NHS Trust, UK
Title:
Cancer stem cells in isocitrate dehydrogenase wild type glioblastoma express components of the
renin-angiotensin system and cathepsins B, D and G
Tinte Itinteang,
Gillies McIndoe Research Institute, Wellington, New Zealand
Title:
The expression of the classical stem cell markers in pancreatic adenocarcinoma cell line
Hussain R Al-Turaifi,
Newcastle University, UK
Title:
The activation of RAF/MEK/ERK kinase cascade by variable
β
3-
α
C loop deletions triggers
oncogenesis
Hu Jiancheng,
National Cancer Centre Singapore, Singapore
Title:
Identification of a novel target that regulates breast cancer stem cells
Monther Al-Alwan,
King Faisal Specialist Hospital and Research Centre, Saudi Arabia
Title:
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma development
Thierry Virolle,
Institut de Biologie Valrose- Ibv, France
Session Introduction
Title:
Stem cell transplantation: A new treatment for blood cancer patients
Naser Mobarra,
Golestan University of Medical Sciences, Iran
Session Introduction
Video Presentation